NEUROPSYCHOLOGICAL FACTORS AND TREATMENT RESPONSE FOR PARKINSONISM WITH COMBINED LEVODOPA AND AMANTADINE

被引：0

作者：

KRAVITZ, EA ^{[1
]}

SCHWARTZ, ML ^{[1
]}

BAUER, RB ^{[1
]}

MCHENRY, JT ^{[1
]}

机构：

[1] WAYNE STATE UNIV,SCH MED,DETROIT,MI

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1973年 / 14卷 / 01期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：148 / 148

页数：1

共 50 条

[41] Levodopa response in parkinsonism with multiple mitochondrial DNA deletions
Wilcox, R. A.
Churchyard, A.
Dahl, H.
Hutchinson, W.
Kirby, D.
Thyagarajan, D.
MOVEMENT DISORDERS, 2007, 22 : S268 - S268
[42] RELATIONSHIP OF PLASMA CONCENTRATIONS OF LEVODOPA TO CLINICAL RESPONSE IN PARKINSONISM
ALLEN, JG
CALNE, DB
DAVIES, CA
REID, JL
BRITISH JOURNAL OF PHARMACOLOGY, 1971, 43 (02) : P464 - &
[43] Amantadine's role in the treatment of levodopa-induced dyskinesia
Rodnitzky, Robert L.
Narayanan, Nandakumar S.
NEUROLOGY, 2014, 82 (04) : 288 - 289
[44] LONG-TERM EVALUATION OF AMANTADINE AND LEVODOPA COMBINATION IN PARKINSONISM BY DOUBLE-BLIND CROSSOVER ANALYSES
FAHN, S
ISGREEN, WP
NEUROLOGY, 1975, 25 (08) : 695 - 700
[45] AMANTADINE VERSUS TRIHEXYPHENIDYL IN TREATMENT OF NEUROLEPTIC-INDUCED PARKINSONISM
FANN, WE
LAKE, CR
AMERICAN JOURNAL OF PSYCHIATRY, 1976, 133 (08) : 940 - 943
[46] Drug monitoring in the blood and the brain on the treatment of parkinsonism - levodopa
Nomoto, M
Nomura, T
Nomura, M
Kaseda, S
Iwata, S
Shimizu, T
Miyata, A
JAPANESE JOURNAL OF PHARMACOLOGY, 2002, 88 : 282P - 282P
[47] RO 4-4602 AND LEVODOPA IN TREATMENT OF PARKINSONISM
MILLER, EM
WIENER, L
NEUROLOGY, 1974, 24 (05) : 482 - 486
[48] Dramatic improvement by levodopa treatment in a patient with vascular parkinsonism
Halil Onder
Neurological Sciences, 2019, 40 : 423 - 425
[49] Dramatic improvement by levodopa treatment in a patient with vascular parkinsonism
Onder, Halil
NEUROLOGICAL SCIENCES, 2019, 40 (02) : 423 - 425
[50] Antipsychotic treatment changes in incident parkinsonism treated with levodopa
de Germay, Sibylle
Rascol, Olivier
Montastruc, Jean-Louis
Lapeyre-Mestre, Maryse
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 150 - 150

← 1 2 3 4 5 →